This article was originally published in The Tan Sheet
FDA's six-month expiration date limitation for repackaged unit-dose drugs places registered and inspected repackaging firms "at a disadvantage" compared to drugstores, hospitals and nursing home facilities that repackage unit-dose drugs using a one-year expiration date pursuant to USP standards, Palm Harbor, Fla.-based Peiser & Associates says in recent citizen petition. Filed on behalf of several repackaging firms, petition asserts "hospitals and clinics who utilize outside packaging services prefer to receive at least a one-year expiration date" and urges FDA to enforce USP standards. Agency compliance policy guide states enforcement action will not be initiated solely on the basis of a repackaging firm's failure to have stability studies supporting expiration dates as long as dates do not exceed six months...
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.